The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.149
Abstract: 149Background: Patients with metastatic hormone-sensitive prostate cancer (mHSPC) have a variable response to ADT and some benefit from the addition of docetaxel or an androgen signaling pathway in... read more here.
Keywords: prostate; impact expression; prostate cancer; expression transcription ... See more keywords